April 2020 - Page 335 of 444

Canadian Stock Exchange News - April 9, 2020

NexTech Reports Record Breaking Revenue and Gross Profit for March

NEW YORK, April 09, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (the “Company” or “NexTech”) (OTCQB: NEXCF) (CSE: NTAR) (FSE: […]

TSX News - April 9, 2020

Dundee Precious Metals Delivers Another Strong Operational Quarter; Announces First Quarter 2020 Preliminary Production Results

TORONTO, April 09, 2020 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announced strong preliminary […]

TSX Venture News - April 9, 2020

Visionstate’s Latest Technology to Raise Bar on Hygiene Compliance Amid COVID-19

EDMONTON, Alberta, April 09, 2020 (GLOBE NEWSWIRE) — Visionstate Corp. (TSX-V: VIS) (“Visionstate” or “the Company”) is pleased to announce […]

NASDAQ Companies - April 9, 2020

Aravive Announces Board Composition and Executive Management Transitions

Healthcare Entrepreneur Fred Eshelman, Pharm.D., Appointed Board ChairmanAravive’s Chief Scientific Officer, Gail McIntyre, Ph.D., Appointed CEOAravive to Host Conference Call […]

NASDAQ Companies - April 9, 2020

Clearside Biomedical Establishes Scientific Advisory Board with Distinguished Retinal Physicians

ALPHARETTA, Ga., April 09, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments […]

NASDAQ Companies - April 9, 2020

Kezar Provides Statement Regarding COVID-19 Pandemic

SOUTH SAN FRANCISCO, Calif., April 09, 2020 (GLOBE NEWSWIRE) — Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and […]

NASDAQ Companies - April 9, 2020

Athenex Provides an Update on Oral Paclitaxel FDA Meeting

BUFFALO, N.Y., April 09, 2020 (GLOBE NEWSWIRE) — Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development […]